TrialScandinavian journal of trauma, resuscitation and emergency medicine2018

Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III).

Martin Schultz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.